2 managers · $121M totalData: SEC EDGAR 13F · 2026Q1
Manager holders · last 4 qtrsⓘ
2
2025Q2 – 2026Q1 · -1 QoQ
Total position
$121M
Combined value across tracked managers
Net move this quarter
↑ Adding
Weighted by holders' share change
HolderQ actionValue% of port.Style
Patient CapitalⓘAdd+18.69%$118M4.32%Contrarian growth-value / Time arbitrage
SaberHold$3M1.87%Concentrated value
What managers sayⓘ
2026-07-10Patient Capital ManagementBullFinding Patience in... an Early 2000s Hip-Hop Song?Detail →
2026-07-09Patient Capital ManagementBull2Q26 Portfolio Activity & AttributionDetail →
2026-04-23Patient Capital ManagementNeutral1Q26 Quarterly WebinarDetail →
2026-04-09Patient Capital ManagementBull“The Worst Brings Out the Best in Us” - Dr. Edith EgerDetail →
2026-04-08Patient Capital ManagementBull1Q26 Portfolio Activity & AttributionDetail →
2026-01-14Patient Capital ManagementBullThe More Things Change, The More They Stay The SameDetail →
2025-12-31Southeastern Asset ManagementNeutral4Q25 Partners Fund CommentaryDetail →
2025-12-31Southeastern Asset ManagementNeutral4Q25 Global Fund CommentaryDetail →
Earnings Callsⓘ
Q1 2026April 21, 2026
›
Overview ConclusionThis quarter's results beat expectations, driven by comprehensive improvements in pricing discipline, medical cost management, and reserve releases.
Key DataAdjusted EPS came in at $7.23, above internal plan; the medical cost ratio (MCR) improved from 84.8% to 83.9%; operating cash flow reached $8.9 billion, 1.4 times net income.
Business ProgressOptumHealth achieved a 35% reduction in nursing home admission rates through value-based care models; OptumRx successfully onboarded 800+ new clients; AI investment budget of $1.5 billion, targeting a 2:1 return.
Guidance & OutlookFull-year adjusted EPS guidance raised to >$18.25, reflecting strong first-half momentum; Medicaid is expected to remain loss-making for the full year, with improvement possible only by 2027.
Risk/Highlight SignalsManagement tone was positive, emphasizing that "all businesses are tracking ahead of plan," but remained cautious about the contraction in Medicaid and ACA businesses, noting that AI investment returns will take time to materialize.